Selective reduction of amyloid β42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid β peptide aggregation

Authors
Publication date
Publisher
BMJ Group
Doi
    View on PubMed

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      Last time updated on 11/12/2019